financetom
Business
financetom
/
Business
/
Pluri Shares Rise After Manufacturing Accord With Kadimastem Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pluri Shares Rise After Manufacturing Accord With Kadimastem Set
Jul 18, 2024 8:45 AM

11:24 AM EDT, 07/18/2024 (MT Newswires) -- Pluri ( PLUR ) shares rose said 7.3% in recent Thursday trading after the company's contract development and manufacturing organization signed a tech transfer and manufacturing agreement to make cell therapy product candidates AstroRx and IsletRx for Kadimastem.

The companies are based in Israel. Financial terms weren't disclosed.

AstroRx is designed for the treatment of amyotrophic lateral sclerosis, and IsletRx aims to treat diabetes, Pluri ( PLUR ) said Thursday in a statement.

Price: 5.75, Change: +0.39, Percent Change: +7.27

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved